ANI PHARMACEUTICALS INC — insider transactions
8 transactions on record · ANIP · CIK 1023024
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
8
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
5
Bought, 3m
$0
Sold, 3m
$1.5M
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$401.2K
2026-08-25
Director share, 12m
37.5%
of transactions where role is stated
Current run
8 sells
consecutive same-direction transactions
Net 3m flow
-$1.5M
purchases minus sales
Total on record
8
Transactions
8 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 | 2026-09-15 | 1 | Lalwani Nikhil | Director, CEO | Open market sale | 5,400 | $71.00 | $383.4K | filing |
| 2026-08-27 | 2026-08-19 | 8 | Gosebruch Henry O | Director | Grant or award | 6,662 | $0.00 | — | filing |
| 2026-08-26 | 2026-08-25 | 1 | Lalwani Nikhil | Director, CEO | Open market sale | 5,400 | $74.30 | $401.2K | filing |
| 2026-08-13 | 2026-08-13 | 0 | Cook Meredith | SEC. | Open market sale | 500 | $75.48 | $37.7K | filing |
| 2026-08-11 | 2026-08-10 | 1 | Gutwerg Ori | SVP, GENERICS | Open market sale | 3,162 | $77.00 | $243.5K | filing |
| 2026-07-30 | 2026-07-29 | 1 | CAREY STEPHEN P. | SVP & CFO | Open market sale | 2,850 | $81.36 | $231.9K | filing |
| 2026-07-21 | 2026-07-18 | 3 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Shares withheld for tax | 2,466 | $79.20 | $195.3K | filing |
| 2026-07-14 | 2026-07-13 | 1 | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Open market sale | 500 | $81.84 | $40.9K | filing |